Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of December 08, 2019
Failed Alzheimer’s drug boosts CAR T-cell therapy
Engineered immune cells get a helping hand in new clinical trial for multiple myeloma patients
Immunotherapy trailblazer Dr. Phil Greenberg to receive E. Donnall Thomas Lecture and Prize
American Society of Hematology honors his ‘vision, creativity and scientific rigor’ in T-cell therapy research
How to talk to parents about HPV vaccines
Fred Hutch public health researcher shares science-based tips to help doctors navigate crucial cancer-prevention conversations
Breaking down HIV exclusions in cancer clinical trials
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
Fred Hutch at ASCO: HPV vaccine uptake in U.S., immunotherapy and sarcoma, financial toxicity of cancer, health care disparities and more
The American Society of Clinical Oncology will hold its annual meeting May 31-June 4 in Chicago
Reducing the cancer burden for women around the globe
Dr. Nancy Davidson on improving outcomes for women with breast, lung and colorectal cancer
Could a simple blood test replace the invasive tissue biopsy?
Answer: It’s complicated …
Dr. Yiting Lim named AACR NextGen Star
Charting the landscape of prostate cancer mutations: Postdoc to present work at annual American Association for Cancer Research meeting
Drs. Fred Appelbaum and Phil Greenberg elected to AACR Academy
They are among 22 scientists from around the world to join the 2019 class of Fellows
Fred Hutch at AACR: NextGen star, liquid biopsies, immunotherapy, cancer genetics, health disparities and more
The American Association for Cancer Research will hold its annual meeting March 29–April 3 in Atlanta
Q&A: A new focus on small cell lung cancer
Dr. David MacPherson discusses the state of small cell lung cancer research, how his lab is tackling this deadly disease, and what makes him excited for the future
“Exciting” but early results in trial of immunotherapy for myeloma
Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease
Fred Hutch at ASH: Combo CAR T-cell therapies, long-term outcomes for CAR T patients, early findings on a CAR T for multiple myeloma, gene therapy for sickle cell, and T cells and the microbiome
The 60th American Society of Hematology Annual Meeting will take place Dec. 1–4 in San Diego
Poor quality of life in 1 in 5 caregivers of bone marrow transplant survivors
Largest-ever study IDs risk factors, paves way for interventions to help
Nanoparticles take immunotherapy in new direction
Hutch scientist to use nanoparticles to reprogram macrophages to tackle brain tumors
Gene editing shows promise for sickle cell and related disorders
Preclinical results offer new hope in group of dangerous inborn diseases
Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal
T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers
How the immune system’s key organ regenerates itself
Watch: Hutch researcher discusses harnessing the thymus’s knack for self-repair to boost immune function and help patients
New insights into CAR T-cell therapy's potential side effects
Detailed study of cytokine release syndrome and neurologic toxicities could help make emerging cancer immunotherapies safer
Health disparities may affect end-of-life experiences of minority blood cancer patients
A new study finds ethnic and racial minorities with leukemia or lymphoma are more likely to die in hospital, receive aggressive care in last weeks of life than white patients